Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Osman

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Journal of Translational Genetics and Genomics|August 9, 2021
Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates <i>CXCR4</i> in inherited riskJulie E Feusier, Michael J Madsen, Brian J Avery, et al.
World Journal of Surgery|May 31, 2025
Strategies and Recommendations to Improve Accessibility of Essential Surgery in Rural Settings in OECD Countries: A Scoping ReviewG Osman, Y Kamel, I Konate, et al.
Journal of Oncology Practice|November 14, 2018
Treatment of Acute Promyelocytic Leukemia in AdultsAfaf E G Osman, Jennifer Anderson, Jane E Churpek, et al.
JCO Precision Oncology|June 20, 2025
Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni SyndromeJennie Vagher, Anna Zakas, Lauren Donovan, et al.
Physical & Occupational Therapy in Pediatrics|August 12, 2024
The Creation of an Individualized School Plan for Optimal Inclusion of Students with Osteogenesis ImperfectaG Osman, J Chemtov, C Mercier, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Blood Advances|December 1, 2022
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clonesAfaf E G Osman, Nuria Mencia-Trinchant, Caner Saygin, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitorsCaroline E Wheeler, Samuel S Coleman, Rebecca Hoyd, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 21, 2019
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective studyE Gobbini, R Chiari, P Pizzutillo, et al.
Cancer Research Communications|July 17, 2024
The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint InhibitorsCaroline E Dravillas, Samuel S Coleman, Rebecca Hoyd, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Journal of Translational Genetics and Genomics|August 9, 2021
Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates <i>CXCR4</i> in inherited riskJulie E Feusier, Michael J Madsen, Brian J Avery, et al.
World Journal of Surgery|May 31, 2025
Strategies and Recommendations to Improve Accessibility of Essential Surgery in Rural Settings in OECD Countries: A Scoping ReviewG Osman, Y Kamel, I Konate, et al.
Journal of Oncology Practice|November 14, 2018
Treatment of Acute Promyelocytic Leukemia in AdultsAfaf E G Osman, Jennifer Anderson, Jane E Churpek, et al.
JCO Precision Oncology|June 20, 2025
Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni SyndromeJennie Vagher, Anna Zakas, Lauren Donovan, et al.
Physical & Occupational Therapy in Pediatrics|August 12, 2024
The Creation of an Individualized School Plan for Optimal Inclusion of Students with Osteogenesis ImperfectaG Osman, J Chemtov, C Mercier, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Blood Advances|December 1, 2022
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clonesAfaf E G Osman, Nuria Mencia-Trinchant, Caner Saygin, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitorsCaroline E Wheeler, Samuel S Coleman, Rebecca Hoyd, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 21, 2019
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective studyE Gobbini, R Chiari, P Pizzutillo, et al.
Cancer Research Communications|July 17, 2024
The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint InhibitorsCaroline E Dravillas, Samuel S Coleman, Rebecca Hoyd, et al.
Pageof 10